Mon, 06 Apr 2020 12:35:22 GMT
GSK to tie up with Vir over COVID-19 treatments
The UK drugmaker GlaxoSmithKline is planning to make a $250M investment in Vir Biotechnology and cooperate over the development of treatments for the COVID-19 disease, both companies stated on Monday.